1. Hepatic stellate cells limit hepatocellular carcinoma progression through the orphan receptor endosialin
   Carolin Mogler et al, 2017, EMBO Molecular Medicine CrossRef
2. Prostaglandin E2 receptor 3 (EP3) signaling promotes migration of cervical cancer via urokinase-type plasminogen activator receptor (uPAR)
   Yao Ye et al, 2020, Journal of Cancer Research and Clinical Oncology CrossRef
3. Sorafenib induces variations of the DNA methylome in HA22T/VGH human hepatocellular carcinoma-derived cells
   Edoardo Abeni et al, 2017, International Journal of Oncology CrossRef
4. Mxd1 mediates hypoxia‐induced cisplatin resistance in osteosarcoma cells by repression of the PTEN tumor suppressor gene
   Datong Zheng et al, 2017, Molecular Carcinogenesis CrossRef
5. Long non-coding RNA Rpph1 promotes inflammation and proliferation of mesangial cells in diabetic nephropathy via an interaction with Gal-3
   Panyang Zhang et al, 2019, Cell Death & Disease CrossRef
6. Role of Galectins in the Liver Diseases: A Systematic Review and Meta-Analysis
   Yang An et al, 2021, Frontiers in Medicine CrossRef
7. Mxi1-0 regulates the growth of human umbilical vein endothelial cells through extracellular signal-regulated kinase 1/2 (ERK1/2) and interleukin-8 (IL-8)-dependent pathways
   Weiling Wu et al, 2017, PLOS ONE CrossRef
8. Small interfering RNA-induced silencing of galectin-3 inhibits the malignant phenotypes of osteosarcoma in vitro
   PENGFEI LEI et al, 2015, Molecular Medicine Reports CrossRef
9. Beyond immunohistochemistry and immunocytochemistry: a current perspective on galectin-3 and thyroid cancer
   Jennifer Li et al, 2019, Expert Review of Anticancer Therapy CrossRef
10. Quantitative proteomics reveal the anti-tumour mechanism of the carbohydrate recognition domain of Galectin-3 in Hepatocellular carcinoma
    Mingchao Wang et al, 2017, Scientific Reports CrossRef
11. The emerging role of galectins in high-fatality cancers
    Cherylane Dubé-Delarosbil et al, 2018, Cellular and Molecular Life Sciences CrossRef
12. The roles of galectins in hepatic diseases
    Mei-Juan Sun et al, 2020, Journal of Molecular Histology CrossRef
13. EGF-induced urokinase plasminogen activator receptor promotes epithelial to mesenchymal transition in human gastric cancer cells
    Pingping Wang et al, 2017, Oncology Reports CrossRef
14. Galectin-3 induced by hypoxia promotes cell migration in thyroid cancer cells
    Jiaojiao Zheng et al, 2017, Oncotarget CrossRef
15. Unraveling the pathophysiologic role of galectin‐3 in chronically injured liver
    Devaraj Ezhilarasan, 2023, Journal of Cellular Physiology CrossRef
16. Galectin-3 Determines Tumor Cell Adaptive Strategies in Stressed Tumor Microenvironments
    Ana Carolina Ferreira Cardoso et al, 2016, Frontiers in Oncology CrossRef